Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to CN¥16.50, the stock trades at a forward P/E ratio of 23x. Average forward P/E is 17x in the Chemicals industry in China. Total returns to shareholders of 68% over the past three years. Declared Dividend • Jul 04
Dividend increased to CN¥0.20 Dividend of CN¥0.20 is 900% higher than last year. Ex-date: 9th July 2026 Payment date: 9th July 2026 Dividend yield will be 1.3%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (44% earnings payout ratio) and cash flows (30% cash payout ratio). The dividend has increased by an average of 5.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 30% over the next year, which should provide support to the dividend and adequate earnings cover. Valuation Update With 7 Day Price Move • Jul 03
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to CN¥15.65, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 21x in the Chemicals industry in China. Total returns to shareholders of 57% over the past three years. Announcement • Jun 30
Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2026 Results on Aug 26, 2026 Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2026 results on Aug 26, 2026 Board Change • May 20
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 4 non-independent directors. Independent Director Gang Chen was the last independent director to join the board, commencing their role in 2025. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Announcement • Apr 24
Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 25, 2026 Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 25, 2026, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China Announcement • Mar 31
Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2026 Results on Apr 28, 2026 Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2026 results on Apr 28, 2026 Announcement • Dec 31
Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2025 Results on Apr 24, 2026 Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2025 results on Apr 24, 2026 Announcement • Sep 30
Lianhe Chemical Technology Co.,Ltd. to Report Q3, 2025 Results on Oct 28, 2025 Lianhe Chemical Technology Co.,Ltd. announced that they will report Q3, 2025 results on Oct 28, 2025 Announcement • Sep 18
Lianhe Chemical Technology Co.,Ltd. Approves Board Elections Lianhe Chemical Technology Co.,Ltd. at its EGM held on September 16, 2025, approved election of Wang Ping, Peng Yinsheng and He Chun as non-independent directors and Zhang Yun, Fu Lianfang and Chen Gang as independent directors. Announcement • Jul 02
Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2025 Results on Aug 27, 2025 Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2025 results on Aug 27, 2025 Announcement • Apr 25
Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, Jun 09, 2025 Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, Jun 09, 2025, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China Announcement • Mar 31
Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2025 Results on Apr 29, 2025 Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025 Announcement • Mar 01
Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces an Equity Buyback for CNY 80 million worth of its shares. Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its shares. The shares will be repurchased at CNY 9.50 per share. The shares repurchased will be used for employee stock ownership plans or equity incentives. The program will be funded using the company's own funds or self-raised funds. The program is valid for 12 months. Announcement • Dec 31
Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2024 Results on Apr 25, 2025 Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2024 results on Apr 25, 2025 Reported Earnings • Oct 31
Third quarter 2024 earnings released: EPS: CN¥0.031 (vs CN¥0.084 loss in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.031 (up from CN¥0.084 loss in 3Q 2023). Revenue: CN¥1.38b (up 2.1% from 3Q 2023). Net income: CN¥18.3m (up CN¥118.3m from 3Q 2023). Profit margin: 1.3% (up from net loss in 3Q 2023). Revenue is forecast to grow 9.9% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 37 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Lianhe Chemical Technology Co.,Ltd. to Report Q3, 2024 Results on Oct 31, 2024 Lianhe Chemical Technology Co.,Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024 Announcement • Sep 23
Lianhe Chemical Technology Co.,Ltd.(XSEC:002250) dropped from FTSE All-World Index (USD) Lianhe Chemical Technology Co.,Ltd.(XSEC:002250) dropped from FTSE All-World Index (USD) Reported Earnings • Aug 24
Second quarter 2024 earnings released: EPS: CN¥0.012 (vs CN¥0.027 loss in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.012 (up from CN¥0.027 loss in 2Q 2023). Revenue: CN¥1.51b (down 12% from 2Q 2023). Net income: CN¥11.5m (up CN¥31.5m from 2Q 2023). Profit margin: 0.8% (up from net loss in 2Q 2023). Revenue is forecast to grow 13% p.a. on average during the next 2 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 41% per year, which means it has not declined as severely as earnings. Declared Dividend • Jul 08
Dividend reduced to CN¥0.02 Dividend of CN¥0.02 is 80% lower than last year. Ex-date: 12th July 2024 Payment date: 12th July 2024 Dividend yield will be 0.4%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. Announcement • Jun 29
Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2024 Results on Aug 24, 2024 Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2024 results on Aug 24, 2024 Announcement • Apr 29
Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 22, 2024 Lianhe Chemical Technology Co.,Ltd., Annual General Meeting, May 22, 2024, at 13:30 China Standard Time. Location: No. 3, Shiji Avenue, Huangyan District, Taizhou, Zhejiang China Reported Earnings • Apr 28
First quarter 2024 earnings released: EPS: CN¥0.003 (vs CN¥0.05 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.003 (down from CN¥0.05 in 1Q 2023). Revenue: CN¥1.47b (down 25% from 1Q 2023). Net income: CN¥2.69m (down 94% from 1Q 2023). Profit margin: 0.2% (down from 2.3% in 1Q 2023). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has fallen by 38% per year, which means it is performing significantly worse than earnings. New Risk • Apr 16
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 3.0x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (3.0x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Announcement • Mar 30
Lianhe Chemical Technology Co.,Ltd. to Report Q1, 2024 Results on Apr 27, 2024 Lianhe Chemical Technology Co.,Ltd. announced that they will report Q1, 2024 results on Apr 27, 2024 New Risk • Mar 11
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks High level of debt (41% net debt to equity). Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. New Risk • Feb 05
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 6.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks High level of debt (46% net debt to equity). Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to CN¥6.07, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 13x in the Chemicals industry in China. Total loss to shareholders of 73% over the past three years. Announcement • Jan 29
Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces an Equity Buyback for CNY 80 million worth of its shares. Lianhe Chemical Technology Co.,Ltd. (SZSE:002250) announces a share repurchase program. Under the program, the company will repurchase up to CNY 80 million worth of its A shares. The shares will be purchased at a price not exceeding CNY 10 per share. The repurchased shares will be used for the implementation of ESOP or equity incentive plan. The program will be valid for 12 months. Announcement • Dec 29
Lianhe Chemical Technology Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 30, 2024 Lianhe Chemical Technology Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 30, 2024 Reported Earnings • Oct 29
Third quarter 2023 earnings released: CN¥0.084 loss per share (vs CN¥0.15 profit in 3Q 2022) Third quarter 2023 results: CN¥0.084 loss per share (down from CN¥0.15 profit in 3Q 2022). Revenue: CN¥1.35b (down 39% from 3Q 2022). Net loss: CN¥100.0m (down 172% from profit in 3Q 2022). Revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has fallen by 31% per year, which means it is significantly lagging earnings. Reported Earnings • Aug 25
Second quarter 2023 earnings released: CN¥0.027 loss per share (vs CN¥0.14 profit in 2Q 2022) Second quarter 2023 results: CN¥0.027 loss per share (down from CN¥0.14 profit in 2Q 2022). Revenue: CN¥1.71b (down 15% from 2Q 2022). Net loss: CN¥20.0m (down 115% from profit in 2Q 2022). Revenue is forecast to grow 23% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 67% per year but the company’s share price has fallen by 32% per year, which means it is significantly lagging earnings. Announcement • Jul 10
Lianhe Chemical Technology Co.,Ltd. Announces 2022 Final Profit Distribution Plan to Be Implemented (A Shares) , Payment Date Is 14 July 2023 Lianhe Chemical Technology Co.,Ltd. announced 2022 final profit distribution plan to be implemented (A shares) of Cash dividend/10 shares (tax included) of CNY1.00000000. Record date is 13 July 2023. Ex-date is 14 July 2023.Payment date is 14 July 2023. Announcement • Jul 01
Lianhe Chemical Technology Co.,Ltd. to Report First Half, 2023 Results on Aug 25, 2023 Lianhe Chemical Technology Co.,Ltd. announced that they will report first half, 2023 results on Aug 25, 2023 Announcement • May 20
Lianhe Chemical Technology Co.,Ltd. Approves Final Cash Dividend for the Year 2022 Lianhe Chemical Technology Co.,Ltd. at the AGM, the shareholders approved a final cash dividend per ten shares (tax included) of CNY 1.00000000 for the year 2022. Reported Earnings • Apr 28
First quarter 2023 earnings released: EPS: CN¥0.05 (vs CN¥0.08 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.05 (down from CN¥0.08 in 1Q 2022). Revenue: CN¥1.96b (up 16% from 1Q 2022). Net income: CN¥44.6m (down 40% from 1Q 2022). Profit margin: 2.3% (down from 4.4% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 2 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has fallen by 11% per year, which means it is significantly lagging earnings. Board Change • Nov 16
Less than half of directors are independent Following the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Director Yun Zhang was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Oct 28
Third quarter 2022 earnings released: EPS: CN¥0.15 (vs CN¥0.10 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.15 (up from CN¥0.10 in 3Q 2021). Revenue: CN¥2.20b (up 27% from 3Q 2021). Net income: CN¥138.1m (up 56% from 3Q 2021). Profit margin: 6.3% (up from 5.1% in 3Q 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 27
Second quarter 2022 earnings released: EPS: CN¥0.14 (vs CN¥0.11 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.14 (up from CN¥0.11 in 2Q 2021). Revenue: CN¥2.01b (up 27% from 2Q 2021). Net income: CN¥130.3m (up 24% from 2Q 2021). Profit margin: 6.5% (down from 6.6% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 11%, compared to a 39% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 20% per year whereas the company’s share price has increased by 19% per year. Board Change • Apr 27
Less than half of directors are independent Following the recent departure of a director, there are only 3 independent directors on the board. The company's board is composed of: 3 independent directors. 5 non-independent directors. Independent Director Shouyun Yu was the last independent director to join the board, commencing their role in 2019. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Mar 10
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥14.17, the stock trades at a forward P/E ratio of 22x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 22% over the past three years. Reported Earnings • Oct 28
Third quarter 2021 earnings released: EPS CN¥0.10 (vs CN¥0.12 in 3Q 2020) The company reported a mediocre third quarter result with weaker earnings and profit margins, although revenues improved. Third quarter 2021 results: Revenue: CN¥1.73b (up 32% from 3Q 2020). Net income: CN¥88.5m (down 22% from 3Q 2020). Profit margin: 5.1% (down from 8.7% in 3Q 2020). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 28% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Aug 22
Second quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.16 in 2Q 2020) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2021 results: Revenue: CN¥1.58b (up 10% from 2Q 2020). Net income: CN¥105.0m (down 28% from 2Q 2020). Profit margin: 6.6% (down from 10% in 2Q 2020). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 44% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Apr 25
Full year 2020 earnings released: EPS CN¥0.12 (vs CN¥0.16 in FY 2019) The company reported a soft full year result with weaker earnings and profit margins, although revenues improved. Full year 2020 results: Revenue: CN¥4.78b (up 12% from FY 2019). Net income: CN¥110.0m (down 24% from FY 2019). Profit margin: 2.3% (down from 3.4% in FY 2019). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 39% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Jan 21
New 90-day high: CN¥26.07 The company is up 8.0% from its price of CN¥24.20 on 23 October 2020. The Chinese market is also up 8.0% over the last 90 days, indicating the company’s price trend is similar to the market over that time. However, it underperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥31.94 per share. Is New 90 Day High Low • Nov 23
New 90-day low: CN¥23.39 The company is down 8.0% from its price of CN¥25.50 on 25 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥27.48 per share. Reported Earnings • Nov 01
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥72.8m, down 79% from the prior year. Total revenue was CN¥4.41b over the last 12 months, down 8.2% from the prior year. Is New 90 Day High Low • Oct 22
New 90-day low: CN¥24.06 The company is down 8.0% from its price of CN¥26.24 on 24 July 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥1.63 per share.